Put Options

16 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$101.05 - $133.57 $6.94 Million - $9.18 Million
-68,700 Reduced 35.71%
123,700 $12.9 Million
Q1 2024

May 15, 2024

SELL
$127.73 - $147.2 $15.3 Million - $17.6 Million
-119,800 Reduced 38.37%
192,400 $26.4 Million
Q4 2023

Feb 14, 2024

BUY
$92.79 - $142.53 $21.6 Million - $33.2 Million
233,000 Added 294.19%
312,200 $43.5 Million
Q3 2023

Nov 14, 2023

BUY
$128.91 - $192.44 $10.2 Million - $15.2 Million
79,200 New
79,200 $10.9 Million
Q1 2023

May 15, 2023

SELL
$193.75 - $232.55 $2.36 Million - $2.84 Million
-12,200 Reduced 32.97%
24,800 $5.77 Million
Q4 2022

Feb 13, 2023

SELL
$187.24 - $242.74 $1.42 Million - $1.84 Million
-7,600 Reduced 17.04%
37,000 $7.48 Million
Q3 2022

Nov 14, 2022

BUY
$177.23 - $227.44 $4.77 Million - $6.12 Million
26,900 Added 151.98%
44,600 $8.51 Billion
Q2 2022

Aug 12, 2022

BUY
$181.58 - $368.0 $3.21 Million - $6.51 Million
17,700 New
17,700 $3.26 Million
Q2 2020

Aug 13, 2020

SELL
$256.46 - $373.01 $692,442 - $1.01 Million
-2,700 Closed
0 $0
Q1 2020

May 13, 2020

BUY
$209.2 - $335.53 $564,840 - $905,930
2,700 New
2,700 $737,000
Q2 2019

Aug 12, 2019

SELL
$300.59 - $368.15 $691,357 - $846,745
-2,300 Closed
0 $0
Q1 2019

May 13, 2019

SELL
$272.57 - $321.18 $7.14 Million - $8.41 Million
-26,200 Reduced 91.93%
2,300 $715,000
Q4 2018

Feb 13, 2019

SELL
$272.46 - $366.54 $5.15 Million - $6.93 Million
-18,900 Reduced 39.87%
28,500 $8.55 Million
Q3 2018

Nov 14, 2018

BUY
$279.04 - $367.06 $10.3 Million - $13.5 Million
36,800 Added 347.17%
47,400 $17.4 Million
Q2 2018

Aug 14, 2018

BUY
$228.17 - $292.07 $1.87 Million - $2.39 Million
8,200 Added 341.67%
10,600 $2.96 Million
Q1 2018

May 15, 2018

BUY
$209.54 - $253.91 $502,896 - $609,384
2,400 New
2,400 $567,000

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22.2B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Capital Fund Management S.A. Portfolio

Follow Capital Fund Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.